These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21448943)

  • 21. Preclinical Arterial Spin Labeling Measurement of Cerebral Blood Flow.
    Muir ER
    Methods Mol Biol; 2018; 1718():59-70. PubMed ID: 29341002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of perinatal arterial ischemic stroke using noninvasive arterial spin labeling perfusion MRI.
    De Vis JB; Petersen ET; Kersbergen KJ; Alderliesten T; de Vries LS; van Bel F; Groenendaal F; Lemmers PM; Hendrikse J; Benders MJ
    Pediatr Res; 2013 Sep; 74(3):307-13. PubMed ID: 23797533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional cerebral blood flow in Parkinson's disease with and without dementia.
    Firbank MJ; Colloby SJ; Burn DJ; McKeith IG; O'Brien JT
    Neuroimage; 2003 Oct; 20(2):1309-19. PubMed ID: 14568499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial spin labeling magnetic resonance imaging at short post-labeling delay reflects cerebral perfusion pressure verified by oxygen-15-positron emission tomography in cerebrovascular steno-occlusive disease.
    Itagaki H; Kokubo Y; Kawanami K; Sato S; Yamada Y; Sato S; Sonoda Y
    Acta Radiol; 2021 Feb; 62(2):225-233. PubMed ID: 32295388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arterial spin labeling in patients with chronic cerebral artery steno-occlusive disease: correlation with (15)O-PET.
    Kamano H; Yoshiura T; Hiwatashi A; Abe K; Togao O; Yamashita K; Honda H
    Acta Radiol; 2013 Feb; 54(1):99-106. PubMed ID: 23091237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of cerebral perfusion and cerebrovascular reserve using Turbo-QUASAR arterial spin labeling MRI.
    Zhao MY; Václavů L; Petersen ET; Biemond BJ; Sokolska MJ; Suzuki Y; Thomas DL; Nederveen AJ; Chappell MA
    Magn Reson Med; 2020 Feb; 83(2):731-748. PubMed ID: 31513311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neuroradiologist's guide to arterial spin labeling MRI in clinical practice.
    Grade M; Hernandez Tamames JA; Pizzini FB; Achten E; Golay X; Smits M
    Neuroradiology; 2015 Dec; 57(12):1181-202. PubMed ID: 26351201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla.
    Sugimori H; Fujima N; Suzuki Y; Hamaguchi H; Sakata M; Kudo K
    Magn Reson Imaging; 2015 Dec; 33(10):1338-1344. PubMed ID: 26260545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial spin labeling perfusion predicts longitudinal decline in semantic variant primary progressive aphasia.
    Olm CA; Kandel BM; Avants BB; Detre JA; Gee JC; Grossman M; McMillan CT
    J Neurol; 2016 Oct; 263(10):1927-38. PubMed ID: 27379517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.
    Cheng L; Wu X; Guo R; Wang Y; Wang W; He P; Lin H; Shen J
    BMC Med Imaging; 2020 Jul; 20(1):78. PubMed ID: 32660445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.
    Shirzadi Z; Stefanovic B; Chappell MA; Ramirez J; Schwindt G; Masellis M; Black SE; MacIntosh BJ
    J Magn Reson Imaging; 2018 Mar; 47(3):647-655. PubMed ID: 28681479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.
    Robertson AD; Messner MA; Shirzadi Z; Kleiner-Fisman G; Lee J; Hopyan J; Lang AE; Black SE; MacIntosh BJ; Masellis M
    Parkinsonism Relat Disord; 2016 Jan; 22():80-6. PubMed ID: 26639982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis.
    Dury RJ; Falah Y; Gowland PA; Evangelou N; Bright MG; Francis ST
    Eur Radiol; 2019 Apr; 29(4):2027-2033. PubMed ID: 30280247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of cerebral perfusion territories using territorial arterial spin labeling: techniques and clinical application.
    Hartkamp NS; Petersen ET; De Vis JB; Bokkers RP; Hendrikse J
    NMR Biomed; 2013 Aug; 26(8):901-12. PubMed ID: 22807022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
    Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
    NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.